MACKENZIE NUTT: Open Payments
NPI 1083095251 · PENNINGTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,371 in 150 payments from 19 companies in 2025. Trend: 2023 $179 · 2024 $1,192 · 2025 $2,371
Food & beverage: $2,175Education: $196
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $405 |
| Incyte Corporation | 19 | $275 |
| Amgen Inc. | 21 | $221 |
| Regeneron Healthcare Solutions, Inc. | 8 | $210 |
| MAYNE PHARMA COMMERCIAL LLC | 17 | $208 |
| Galderma Laboratories, L.P. | 11 | $152 |
| Organon LLC | 11 | $124 |
| Novartis Pharmaceuticals Corporation | 4 | $123 |
| PFIZER INC. | 6 | $121 |
| LEO Pharma Inc. | 6 | $113 |
Products named: SKYRIZI, OPZELURA, OTEZLA, DUPIXENT, NEMLUVIO, CIBINQO, TREMFYA, RINVOQ.
Industry payments across NJ — which companies pay providers there.
